Alzheimer's disease:
The only treatment available today that really works
Alzheimer's disease is the number one neurodegenerative disease affecting the population. The incidence of Alzheimer's disease in its full-blown form reaches up to 15% of the population at age 70 and perhaps 50% of the population by age 80.
Many times the symptoms are attributed to age-related cognitive decline, a seemingly benign condition which doesn't get the same respect as full-blown Alzheimer's disease in terms of its severity. Nonetheless, it creates a considerable amount of anxiety for the patient and the family as they realize the implications of this disease.
How does it feel if someone was to watch their mother or father lose all cognitive awareness and succumb to the effects of Alzheimer's disease, and then realize that they are starting to suffer the exact same circumstances? How does it feel for the next generation to watch their grandmother or grandfather suffer the indignity associated with this horrible disease, then see their parent showing exactly the same signs in the earlier stages, and expecting nothing better for themselves as they get older?
We are watching a population with the most severe neurodegenerative diseases afflicting a greater and greater percentage of our older population, and at the same time we are seeing some evidence of this disease affecting younger and younger people.
Many experts have noted some sort of the link between cardiovascular disease, especially atherosclerosis, and a number of age-related neurological disorders. They believe there is a relationship to inflammation. Other diseases that have a similar association with inflammation include autoimmune diseases, obesity, diabetes, infections, exposure to toxic metals, solvents, pesticides and herbicides, trauma, and consumption of omega 6 fats far in excess of what our body needs.
Studies have shown that patients who have been given flu vaccine 5 years a row have a greatly increased incidence of Alzheimer.
Flu vaccine contains thiomerisol, which is a mercury based preservative. The amount of mercury the patient can get from one flu vaccine injection is many times higher than any supposedly acceptable level of mercury ingestion or injection.
The exposure to pesticides and herbicides on the foods we eat greatly taxes our bodies' ability to remove these poisons, leaving us with the poisons in the body creating major damage to the nervous system.
This damage to our nervous system creates the Alzheimer's disease and other neurodegenerative diseases. It is the toxic buildup that creates the damage in our body that leads to the inflammation that leads to the deterioration of all of the systems of body, but most particularly the nervous system. The toxins that get into our bodies are lipophilic toxins and they go to the fatty tissues. Pesticides are created to be lipophilic. Lipophilic means that the substance likes fat and will go where there are fat stores in the body. The brain and the nervous system is the organ system in the body with the greatest amount of fat tissue. Pesticide manufacturers use this characteristic to manufacture pesticides that will go to the nervous system to kill the pest. An unintended effect, perhaps, is the damage to the human nervous system when these poisons get into the body and stay there doing their damage to us.
Over the past several years many forms of treatment have been tried for Alzheimer's disease.
Attempts have been made to use estrogen therapy as a means of delaying the onset of the disease. It had limited effect if any. It had no effect on the patient once the Alzheimer's symptoms became most apparent.
The most common medications for Alzheimer's involve the use of a group of medications considered cholinesterase inhibitors. Brand names such as Aricept, Razadyne, and Exelon comprise this group of medications which are intended to increase the level of acetylcholine, a neurotransmitter in the brain of people afflicted with Alzheimer's.
This approach is directed at one single neurotransmitter as if that is the only problem going on in the brain.
The patient's who have taken these medications usually tolerates them, however significant side effects also occur. The side effects nausea, diarrhea, vomiting, indigestion, abdominal pain, loss of appetite, and weight loss.
The benefits that are achieved using these medications are minimal at best and totally not effective in most patients.
Some have recommends vitamins and other nutraceuticals, all with very limited benefits, if any at all.
The end result of the available treatment plans is observing the patient getting worse and worse and ultimately succumbing to the effects of this horrible disease.
There is, however, a form of treatment that has had incredibly positive results with no side effects.
This approach also deals with the idea of neurotransmitters. It recognizes that damage to the nervous system has occurred throughout the brain and multiple levels of nerve function are interfered with by the damage. The neurotransmitters in general are unable to function because of this damage. The proper amount of master neurotransmitters is not present where it is needed and the patient is not functional.
Neurotransmitters are the chemicals that make our nerves work. If they are depleted in the body, or if they are not there in high enough quantities to over come the damage done to the nerves, the body does not function well. We go into an "electrical brownout" where the nerve impulses are too weak to do their function of running the body.
The method that has evolved from Neuroresearch clinics involves restoring appropriate levels of the master neurotransmitters serotonin and the catecholamine group including dopamine, noradrenaline, and adrenaline. It is important to deal with the master neurotransmitters as a balanced group and restore their function. Once the master neurotransmitters are working the other neurotransmitters will fall into place.
To this end, we use a balanced formulation of 5 hydroxytryptophan, tyrosine, and L-dopa to restore the master neurotransmitter levels to therapeutic phase 3 status, as measured by specific urine testing. Each patient's dosage is individualized. A protocol has been worked up now where the patient starts on level 1, is increased to level 2 or level 3 depending upon the response of the patient.
If the patient has not achieved a return to full function, and feels well, we then use the urine testing to measure the levels of serotonin and dopamine in the urine and change the dosage of the respective amino acids to achieve the proper balance in the body.
What have we seen with this approach?
An 87-year-old female patient who was almost completely noncommunicative, and was measured on psychological testing to be completely nonfunctional and full-blown Alzheimer's disease, appropriate to be committed to Alzheimer facility was restored to full communication, and able to go back and live in her own home with a companion.. The dose was titrated to fit this patient and she remained functional for many months. The patient had to go into a hospital for a nonrelated matter. During the hospitalization, the hospital staff refused to give the patient her nutritional supplements. After two days off of the supplements the patient reverted back to the noncommunicative phase.
When the patient was removed from the hospital after completion of the treatment, she was put back on her proper dose of nutritional amino acids. Within two days she returned to her prehospital level of communication ability. The same thing happened on several additional occasions for other unrelated medical problems. Each time these supplements were removed the patient stopped talking. Each time the supplements were started again, the patient returned to her functional level.
This case is a clear-cut indication that the nutritional supplementation with the amino acids is the direct reason for the patient's ability to function as it restores the levels of neurotransmitters to functional levels in the body and especially in the brain and allows the patient to overcome the symptoms of Alzheimer.
In another case, an 82 year old male had his 3rd heart attack .This
was accompanied by a bout of pneumonia while in the hospital. In the
past 4 years, he was also experiencing increasing problems with Alzheimer's
dementia and memory problems. Prior to retiring from his employment,
he had been a chef. His wife reported, "Now he can't even cook
an egg."
Upon returning home from the hospital, his confusion and memory problems
were even more pronounced. He appeared to be in a chronic confusion
state. His wife reported he was not sleeping at night and would wander
the house for hours each night.
He was started on the level 1 5- hydroxytryptophan (5-HTP), tyrosine, levodopa, and cysteine dosing. After one week, his wife reported that he was now sleeping at night, but there was no change in his confusion or memory. So, after one week, the dose was increased for the 5-HTP, tyrosine, levodopa, and cysteine to level 2. One week later his wife reported, "He is sleeping like a baby all night and he is no longer talking about things that aren't there". Memory was showing marginal signs of improvement. At that point, the dose of the 5-HTP, tyrosine, levodopa, and cysteine was again increased to level 3. One week later, his wife said "He is back with me." His sleep was excellent, his speech was fluent, and he had cooked breakfast for both of them that morning for the first time in two years. The wife reported that he was now participating in conversations relating to things they had done years earlier with no memory problems. They were working around the house together once again doing projects.
The dramatic improvement was a surprise at that time. In elderly people with Alzheimer's dementia and decreased cognitive function, an empirical trial of 5-HTP, tyrosine, levodopa, and cysteine may lead to profound results with no downside risks.
In another case a gentleman brought his wife to a physician stating "she's got Alzheimer's". "Can you help"? The gentleman's wife was an artist and had sold much of her work. She lost her ability to draw and couldn't remember anything.
She couldn't remember breakfast, who was the president, or any question that was asked of her. She looked to her husband for every answer. She was making a full downhill course toward full-blown Alzheimer's. The patient was started on Neuroresearch clinic program level 1, and gradually moved up through level 2 to level 3. Four weeks after she started on the program she was able to tell the name of the president and vice president and she was back painting pictures, beautiful pictures once again. The physicians at the University where she had been previously treated were finding it difficult to appreciate the progress that the patient had made. The patient's husband stated "why don't the other doctors know about this or do it this way"? "I feel we have wasted so much time and money".
We have seen this scenario time and again with other Alzheimer's patients.
Improvement is noted even in the first week of dosage change. Patient's
becoming awake, communicating, recognizing things, not asking repetitive
questions, not getting lost when they are in a car or walking on the
street, remembering meals that they ate and the simple tasks that they
did.
The patient unwilling to go out of the house with her husband to have
lunch was able to drive the car to the restaurant. One patient had gotten
lost a half a mile from the house, and was unable to go back home, now
felt confident when she went around the neighborhood. These may be small
things to some but they are monstrous improvements to an Alzheimer's
patient.
We are seeing these results regularly. I know of no other treatment
that is able to show this type of improvement.
More information about this treatment is available by visiting the website at www.neuroassist.com or www.proloshot.com.
Is there anything better than getting a functional lifestyle back again? Take the next step for your family's sake and for your own sake.
Alvin Stein, MD, FACS
6766 W Sunrise Blvd, Suite 100A
Plantation, FL 33313
954-581-8585
